Since 2005, Ultradian Diagnostics has been driven by an unmet need for high-quality, wearable diagnostic devices capable of lowering costs and improving health care through superior accuracy and performance. Our management team is driven by a vision to provide users and clinicians with diagnostic tools to successfully monitor and manage chronic illnesses in a cost effective manner. Our focus on developing a flexible architecture that minimizes sensor drift and signal noise makes the Company truly unique in the marketplace.

Ultradian is a member of the New York Biotechnology Association and was named a 2010 Tech Company to Watch by the Connecticut Technology Council.